Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0926
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Molecular Stratification Within Triple-Negative Breast Cancer Subtypes

Scientific Reports
Multidisciplinary
2019English

Expression of Androgen Receptor and C-Kit (CD117) in Triple Negative Breast Cancer

Immunopathology, Allergology, Infectology
2016English

Molecular Subtypes of Triple-Negative Breast Cancer in Women of Different Race and Ethnicity

Oncotarget
Oncology
2018English

BCL11A Confers Cell Invasion and Migration in Androgen Receptor‑positive Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

The Relationship Between Androgen Receptor, Components of Tumour Microenvironment and Survival in Breast Cancer Molecular Subtypes

Cancer therapy & Oncology International Journal
2018English

A Comparison of the Molecular Subtypes of Triple-Negative Breast Cancer Among Non-Asian and Taiwanese Women

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Genes Associated With Histopathologic Features of Triple Negative Breast Tumors Predict Molecular Subtypes

Breast Cancer Research and Treatment
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy